Jiangxi Bio Unit Wins China Nod for Veterinary Tetanus Antitoxin
Jiangxi Institute of Biological Products' (HKG:6915) wholly owned subsidiary, Chifeng Bo-en Pharmaceutical, received an approval certificate from Chinese regulators for its veterinary tetanus antitoxin, according to a Friday Hong Kong bourse filing. The product is used to prevent and treat tetanus infections in animals by neutralizing tetanus toxin and providing passive immune protection to animals at risk of infection.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.